As Program Director Helena oversees several programs at The Synergist, acting as the Executive Director of the From Testing to Treatment Program (FT3P), the Motherhood Collective Impact Program (Pregnancy & Medicine Initiative, Alliance for Maternal Health Equality, Safe Motherhood Week), and The Synergist's contribution to IMI ConcePTION and SYNCHROS. In a world where we are better equipped to solve society's problems than ever, but important issues such as in healthcare and in the environment remain unsolved, Helena connects people together to solve the world’s most challenging issues. Building real collective impact and shared value, her interest is in using the power of digital to establish and manage collaborative partnerships that are genuinely able to take action and make a tangible difference. Her specialty and personal interest is in connecting diverse people around issues and insights to solve social and business problems - such as experts and academics, NGOs, companies, and the general public - including many who do not realise they can contribute something to make an impact. Connections include through traditional in-person means or non-traditional, bespoke digital solutions. A key value Helena brings is establishing clarity, purpose and structure to unlock high performance of teams, from within start-up environments or established organisations. She has extensive experience in project and programs management, managing complex international and multi-stakeholder projects closely to deliver consistently high-quality results on budget and on time. Comfortable in start-up environments, Helena has implemented new processes and procedures from the ground up, such as installing an effective agile/scrum methodology company-wide. Helena is multi-lingual and multi-cultural, having lived and worked in the USA, France, Belgium, the UK and Japan. She has worked on projects across several industry sectors, from Finance to Healthcare.
The Synergist runs programmes aimed at solving challenges which others ignore or have been unable to resolve. Our approach is a bit different. We’re not issue experts. We focus primarily on bringing the most important stakeholders together and building shared value, rather than trying to do it all ourselves. Given the complexity of the world we live in and the challenges we face, we’re convinced there is no better way.
The Patient Focused Medicines Development (PFMD) group, established in 2015, is an independent multinational coalition, managed in collaboration with The Synergist. Its goal is to bring together initiatives and best practices that integrate the voice of the patient throughout the lifecycle of medicines development, thereby speeding up the creation and implementation of an effective, globally standardized framework. PFMD seeks to have a balanced representation of stakeholders to ensure transparency, inclusiveness, and credibility. Stakeholders include patients and patient organizations across diverse areas of health and industry. We also intend to invite regulators, payers and other professional organizations to the global group to ensure diversity of perspectives.
I commit to communicating our activities and outputs to patients and future patients so they can benefit from the work we are doing.Work in progress
I commit to bringing diverse people together to collaborate on improving patient engagement including those who may not ever know yet that they can make a positive impact.Work in progress
I commit to practicing empathy and listening to new points of views and ideas without prejudice.Work in progress